Professor Saul Faust

Business news, market intelligence, and global industry analysis.

The Latest

Philadelphia jury orders Johnson & Johnson to pay $250,000 in talc powder lawsuit

Representative image showing the intersection of financial performance and cancer diagnostics, reflecting Exact Sciences’ record 2025 results and its pending acquisition by Abbott Laboratories.

Exact Sciences (NASDAQ: EXAS) earnings show why Abbott moved now on a $21bn diagnostics acquisition

Representative image. Global technology leaders collaborate on cross-border trust frameworks as the Trusted Tech Alliance launches to shape standards for AI, cloud infrastructure, and digital sovereignty.

Why the world’s biggest tech firms are racing to define trust before governments do

Bank of America boosts Brian Moynihan’s 2025 pay to $41m amid governance scrutiny

Representative image: Stablepharma locks database for Phase I SPVX02 trial, advancing its fridge-free vaccine mission.

Fridge-free vaccine milestone: Stablepharma locks Phase I SPVX02 data in thermostability push

Stablepharma has completed its first human trial for SPVX02, a fridge-free tetanus-diphtheria vaccine designed to work without cold-chain storage. With the data now locked, the company is preparing to scale its thermostable platform for global deployment.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

November 2, 2025